Marvaso, G., Francolini, G., Achard, V. et al. (4 more authors) (2025) Should We Embark on “EMBARK”? Reassessing the Role of Radiotherapy and Androgen Receptor Pathway Inhibitors in the Era of Next-generation Imaging. European Urology. ISSN: 0302-2838 (In Press)
Abstract
Results from the EMBARK trial reshape the treatment paradigm for high-risk biochemical recurrence of prostate cancer. EMBARK data support the use of androgen receptor pathway inhibitors combined with metastasis-directed therapy in a personalized, multidisciplinary care approach for this subset of patients.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | This is an author produced version of an article published in European Urology, made available under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Keywords: | Urology Focus Group of the European Society for Radiotherapy and Oncology |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) |
| Date Deposited: | 13 Nov 2025 14:08 |
| Last Modified: | 13 Nov 2025 14:08 |
| Published Version: | https://www.sciencedirect.com/science/article/pii/... |
| Status: | In Press |
| Publisher: | Elsevier |
| Identification Number: | 10.1016/j.eururo.2025.08.020 |
| Related URLs: | |
| Sustainable Development Goals: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:234311 |
Download
Filename: Editorial Urology focus group of ESTRO Cleaned version 2.pdf
Licence: CC-BY 4.0


CORE (COnnecting REpositories)
CORE (COnnecting REpositories)